Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dosefinding trial

다국어 초록 (Multilingual Abstract)

Lactobacillus gasseri BNR17 is a strain isolated from human breast milk. The objective of this randomized, double-blind, placebo-controlled, and preliminary dosefinding trial was to find the effective dose and evaluate the effect of Lb. gasseri BNR17 on irritable bowel syndrome (IBS) symptoms. A total of 55 volunteers aged over 20 years with body mass index over 23 kg/m2 were randomized to intake a placebo, low-dose (BNR-L, 2 9 108 CFU/day), intermediate-dose (BNR-M, 2 9 109 CFU/day), or high-dose BNR (BNR-H, 2 9 5 9 109 CFU/day) for four weeks. Questionnaire for IBS symptoms scores and Lb. gasseri BNR17 in feces were assessed at the beginning and end of the trial. Among IBS symptoms scores, abdominal pain score was significantly reduced in BNR-H group. Lb. gasseri BNR17 was detected in all intake groups except placebo. In the preliminary study, Lb. gasseri BNR17 was confirmed to have probiotic properties.

참고문헌 (Reference)

1 Brenner DM, "The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review" 104 : 1033-1049, 2009

2 Brandt LJ, "Systematic review on the management of irritable bowel syndrome in North America" 97 : S7-S26, 2002

3 Yao X, "Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study" 27 : 760-765, 2012

4 Alok A, "Probiotics: A New Era of Biotherapy" 6 : 31-, 2017

5 Whelan K, "Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews" 14 : 581-587, 2011

6 Olivares M, "Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults" 107 : 104-111, 2006

7 Takahashi H, "Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract" 50 : 867-870, 2006

8 Jingrui Wang, "Isolation, Identification, and Potential Probiotic Characterization of One Lactococcus from Kefir Grain" 한국식품과학회 24 (24): 1775-1780, 2015

9 Haller D, "Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome" 140 : 690S-697S, 2010

10 Zimmerman J, "Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms" 48 : 743-749, 2003

11 정혜경, "Estimating the Burden of Irritable Bowel Syndrome: Analysis of a Nationwide Korean Database" 대한소화기 기능성질환∙운동학회 20 (20): 242-252, 2014

12 Fujiwara S, "Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism" 90 : 343-352, 2001

13 Takagi A, "Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial" 2016 : 2016

14 Ji-Hee Kang, "Effects of Lactobacillus gasseri BNR17 on Body Weight and Adipose Tissue Mass in Diet-Induced Overweight Rats" 한국미생물학회 48 (48): 712-714, 2010

15 Andreasen AS, "Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects" 104 : 1831-1838, 2010

16 Yun SI, "Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes" 107 : 1681-1686, 2009

17 정승필, "Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial" 대한가정의학회 34 (34): 80-89, 2013

18 Quan C, "Development and validation of the Diabetes Bowel Symptom Questionnaire" 17 : 1179-1187, 2003

19 Ducrotte P, "Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome" 18 : 4012-4018, 2012

20 Jankovic I, "Application of probiotics in food products-challenges and new approaches" 21 : 175-181, 2010

21 Kang JH, "Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice" 8 : e54617-, 2013

22 American College of Gastroenterology Task Force on Irritable Bowel S, "An evidence-based position statement on the management of irritable bowel syndrome" 104 (104): S1-S35, 2009

23 Kajander K, "A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention" 22 : 387-394, 2005